TG/HDL-C ratio — free insulin-resistance signal from an existing lipid panel — Philadelphia, PA.

Philadelphia, PA is the headquarters of the American College of Physicians (ACP) -- founded 1915, 162,000+ members, the largest medical-specialty organization in the US -- which publishes Annals of Internal Medicine, the exact journal this standard's foundational citation (McLaughlin, Abbasi, Cheal, Chu, Lamendola, Reaven. Ann Intern Med. 2003;139(10):802-809) appeared in, confirmed via WebFetch to Wikipedia. No honesty-limit caveat needed: the ACP is the direct publisher of the citation's own journal. Distinct from the existing Jackson tile, which is built on the Jackson Heart Study's own cohort finding about this ratio's population limit rather than the origin citation's publishing society. This ratio is a free derived number from an existing lipid panel, computed where the journal publishing its original population threshold is headquartered.

Where

Telehealth / Philadelphia, PA (compute over an existing lipid panel) · Open the map

Pay

$80 proposed

This packet is not funded yet, so this figure is a proposed price and not money waiting in escrow. If a buyer funds it, approved proof settles that price onchain. If nobody funds it, approved proof earns provable credit toward the work instead of cash — recorded, and readable any time at vealth.net/labor/credit/(your wallet). You see which before you claim, never after.

Proof

TG (mg/dL) and HDL-C (mg/dL) from an accredited-lab lipid panel already on file + the computed ratio + the population-appropriate interpretation (or explicit non-applicability) + routing to the insulin_resistance HOMA-IR standard as the reliable alternative

This is exactly what gets it approved. Nothing settles without it.

Level

entry

Open until

2027-03-02

Posted by

0x034F…6c89

The creator wallet. Its signature is what approves proof and settles the wage.

How this work is done

A documented method, so this packet comes out the same whoever does it.

Bring

• A recent accredited-lab lipid panel report already on file (TG and HDL-C values)
• A calculator
• The person's self-identified race/ethnicity, since the interpretation band depends on it

Steps

1. 1. Locate a recent (ideally <=6 months old) accredited-lab lipid panel already on file; record the TG (mg/dL) and HDL-C (mg/dL) values with the draw date.
2. 2. Compute TG/HDL-C = TG (mg/dL) / HDL-C (mg/dL); show the arithmetic in the record.
3. 3. Ask the person's self-identified race/ethnicity ONLY to select the correct interpretation band — never to make any other inference.
4. 4. For a general/white-cohort population: read >=3.0 as the McLaughlin 2003 insulin-resistance-associated threshold, flagging only.
5. 5. For an African-American woman: state explicitly that the ratio is NOT interpretable for insulin resistance per Sumner et al. 2010 (Jackson Heart Study) -- record 'not applicable, do not use to rule out insulin resistance' rather than any numeric band.
6. 6. For an African-American man: use the Sumner 2010 adjusted threshold of 2.5 (not the general 2.0/3.0 conventions), flagging only.
7. 7. Regardless of band, name the insulin_resistance (fasting insulin + HOMA-IR) standard as the reliable next step if the person wants a direct, population-neutral measurement rather than this free derived signal alone; sign the record.

What counts as done

• TG and HDL-C values (mg/dL) transcribed from an existing accredited-lab lipid panel report, dated
• TG/HDL-C ratio computed and shown with the arithmetic
• Interpretation banded per the population-appropriate evidence: general/white-cohort threshold >=3.0 (McLaughlin 2003); African-American women — ratio explicitly NOT interpretable, stated as such, never used to reassure; African-American men — threshold 2.5, not 2.0 (Sumner 2010)
• The insulin_resistance (fasting insulin + HOMA-IR) standard named as the reliable, population-neutral alternative when this ratio's population limit applies or the result is ambiguous

Proof is measured against these, not judged by taste.